全文获取类型
收费全文 | 3978篇 |
免费 | 211篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 48篇 |
妇产科学 | 45篇 |
基础医学 | 424篇 |
口腔科学 | 86篇 |
临床医学 | 340篇 |
内科学 | 981篇 |
皮肤病学 | 208篇 |
神经病学 | 344篇 |
特种医学 | 126篇 |
外科学 | 659篇 |
综合类 | 14篇 |
一般理论 | 2篇 |
预防医学 | 244篇 |
眼科学 | 114篇 |
药学 | 148篇 |
中国医学 | 2篇 |
肿瘤学 | 349篇 |
出版年
2023年 | 19篇 |
2022年 | 51篇 |
2021年 | 103篇 |
2020年 | 50篇 |
2019年 | 90篇 |
2018年 | 113篇 |
2017年 | 72篇 |
2016年 | 80篇 |
2015年 | 113篇 |
2014年 | 137篇 |
2013年 | 204篇 |
2012年 | 293篇 |
2011年 | 268篇 |
2010年 | 161篇 |
2009年 | 171篇 |
2008年 | 250篇 |
2007年 | 261篇 |
2006年 | 241篇 |
2005年 | 222篇 |
2004年 | 212篇 |
2003年 | 181篇 |
2002年 | 167篇 |
2001年 | 54篇 |
2000年 | 62篇 |
1999年 | 50篇 |
1998年 | 35篇 |
1997年 | 33篇 |
1996年 | 34篇 |
1995年 | 28篇 |
1994年 | 28篇 |
1993年 | 33篇 |
1992年 | 30篇 |
1991年 | 45篇 |
1990年 | 31篇 |
1989年 | 22篇 |
1988年 | 26篇 |
1987年 | 16篇 |
1986年 | 22篇 |
1985年 | 14篇 |
1984年 | 18篇 |
1983年 | 16篇 |
1982年 | 13篇 |
1981年 | 17篇 |
1979年 | 7篇 |
1978年 | 9篇 |
1977年 | 10篇 |
1976年 | 8篇 |
1975年 | 10篇 |
1973年 | 9篇 |
1932年 | 7篇 |
排序方式: 共有4204条查询结果,搜索用时 15 毫秒
41.
Hans Gelderblom Ramon Salazar Jaap Verweij George Pentheroudakis Maja J A de Jonge Martin Devlin Christel van Hooije Francis Seguy Rosendo Obach Joan Pru?onosa Paola Principe Chris Twelves 《Clinical cancer research》2003,9(11):4101-4107
PURPOSE: Diflomotecan (BN80915) is an E-ring modified camptothecin analogue that possesses greater lactone stability in plasma compared with other topoisomerase I inhibitors, a potential advantage for antitumor activity. As with other camptothecins, oral administration has pharmacological and clinical advantages. This Phase I study was performed to assess the feasibility of the administration of oral diflomotecan, to determine the maximum-tolerated, dose its bioavailability, and to explore the pharmacokinetics. EXPERIMENTAL DESIGN: An initial i.v. bolus was administered to assess the bioavailability of diflomotecan. Fourteen days later, diflomotecan was administered p.o. once daily for 5 days to adult patients with solid malignant tumors and repeated every 3 weeks. BN80915 and its open lactone form BN80942 were measured. RESULTS: Twenty-two patients entered the study and received a total of 57 cycles of oral diflomotecan at flat dose levels of 0.10, 0.20, 0.27, and 0.35 mg. The main toxicity was hematological, but some patients experienced alopecia, mild gastrointestinal toxicity, and fatigue. At the 0.35-mg dose level, 2 of 4 patients experienced dose-limiting toxicity comprising grade 3 thrombocytopenia with epistaxis and febrile neutropenia in 1 patient and uncomplicated grade 4 neutropenia lasting for >7 days in another. Toxicity was acceptable at the 0.27-mg dose level at which dose-limiting toxicities were observed in 3 of 12 patients (grade 4 neutropenia > 7 days, complicated by fever in 1 patient but without other signs of infection). After two cycles of diflomotecan, 6 patients had disease stabilization, which was maintained in 2 patients for 9 months and >1 year, respectively. Diflomotecan pharmacokinetics were linear over the dose range studied. Systemic exposure correlated with the fall in WBC counts. The mean oral bioavailability (+/-SD) was 72.24 +/- 59.2% across all dose levels. Urinary excretion of BN80915 was very low. CONCLUSIONS: The recommended oral diflomotecan dose for Phase II studies is 0.27 mg/day x 5 every 3 weeks. This regimen is convenient and generally well tolerated with a favorable pharmacokinetic profile and high but variable bioavailability. 相似文献
42.
Barbara Roa Pauloski Jerilyn A. Logemann Laura A. Colangelo Alfred W. Rademaker Fred M. S. McConnel Mary Anne Heiser Salvatore Cardinale Donald Shedd David Stein Quinter Beery Eugene Myers Jan Lewin Marc Haxer Ramon Esclamado 《The Laryngoscope》1998,108(6):908-916
Postoperative speech function may be influenced by a number of treatment variables. The objective of this study was to examine the relationships among various treatment factors to determine the impact of these measures on speech function. Speech function was tested prospectively in 142 patients with surgically treated oral and oropharyngeal cancer 3 months after treatment. Each patient's speech was recorded during a 6- to 7-minute conversation and while performing a standard articulation test, producing speech outcome measures of percent correct consonant phonemes and percent conversational understandability. Correlational analyses were used to determine the relationships among the speech outcome measures and 14 treatment parameters. Speech function was mildly to moderately negatively correlated with most surgical resection variables, indicating that larger amounts of tissue resected were associated with worse speech function. Overall measures of conversational understandability and percent correct consonant phonemes were related to extent of oral tongue resection, floor of mouth resection, soft palate resection, and total volume of tissue resected. These relationships varied depending on the method of surgical closure. Method of surgical reconstruction had a profound impact on postoperative speech function 3 months after treatment and was an important factor in determining how oral tongue resection influenced articulation and intelligibility. The combination of closure type, percent oral tongue resected, and percent soft palate resected had the strongest relationship with overall speech function for patients with surgically treated oral and oropharyngeal cancer 3 months after treatment. 相似文献
43.
44.
da Costa JP de Sousa MJ Magalhaes T Ribeiro C Grams AC Ramon J Rangel R 《Medicine and law》2000,19(2):309-319
Since 1993 in Portugal, it is possible, by legal enforcement, to request forensic examination to study possible conditions of drug addiction. On the basis of examinations carried out in the Medico Legal Institute of Oporto, we present a study of 494 cases involving the relation to the demographic data of the examined individuals, their family background, legal situation, age at which drug consumption began, consumption profile at the beginning and at time of forensic examination and our conclusions. 相似文献
45.
Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. 总被引:5,自引:0,他引:5
Ali O Gure Ramon Chua Barbara Williamson Mithat Gonen Cathy A Ferrera Sacha Gnjatic Gerd Ritter Andrew J G Simpson Yao-T Chen Lloyd J Old Nasser K Altorki 《Clinical cancer research》2005,11(22):8055-8062
PURPOSE: Cancer-testis genes mapping to the X chromosome have common expression patterns and show similar responses to modulators of epigenetic mechanisms. We asked whether cancer-testis gene expression occurred coordinately, and whether it correlated with variables of disease and clinical outcome of non-small cell lung cancer (NSCLC). EXPERIMENTAL DESIGN: Tumors from 523 NSCLC patients undergoing surgery were evaluated for the expression of nine cancer-testis genes (NY-ESO-1, LAGE-1, MAGE-A1, MAGE-A3, MAGE-A4, MAGE-A10, CT7/MAGE-C1, SSX2, and SSX4) by semiquantitative PCR. Clinical data available for 447 patients were used to correlate cancer-testis expression to variables of disease and clinical outcome. RESULTS: At least one cancer-testis gene was expressed by 90% of squamous carcinoma, 62% of bronchioloalveolar cancer, and 67% of adenocarcinoma samples. Statistically significant coexpression was observed for 34 of the 36 possible cancer-testis combinations. Cancer-testis gene expression, either cumulatively or individually, showed significant associations with male sex, smoking history, advanced tumor, nodal and pathologic stages, pleural invasion, and the absence of ground glass opacity. Cox regression analysis revealed the expression of NY-ESO-1 and MAGE-A3 as markers of poor prognosis, independent of confounding variables for adenocarcinoma of the lung. CONCLUSIONS: Cancer-testis genes are coordinately expressed in NSCLC, and their expression is associated with advanced disease and poor outcome. 相似文献
46.
47.
Oscar J. Balchum MD Ramon D. Buckley PhD Russell Sherwin MD Murray Gardner MD 《Archives of environmental & occupational health》2013,68(2):274-277
A self-refrigerated suit using dry ice as cooling agent and allowing the wearer to move about freely is described. Its efficiency during exposure to heat (dry bulb temperature, ta = 46 C; wet bulb temperature, twb = 35 C) and heavy physical work on a treadmill has been demonstrated by experiments on 26 subjects. The heart rate is reduced and the body temperature is decreased. The way in which this self-refrigerated suit reduces the heat load is discussed and the usefulness of its application is emphasized. 相似文献
48.
49.
E García‐Molina J Lacunza F Ruiz‐Espejo M Sabater A García‐Alberola JR Gimeno F Caizares A García P Martínez M Valds I Tovar 《Clinical genetics》2013,83(6):530-538
We aim to study the SCN5A gene in a cohort of Brugada syndrome (BS) patients and evaluate the genotype–phenotype correlation. BS is caused by mutations in up to 10 different genes, SCN5A being the most frequently involved. Large genomic rearrangements in SCN5A have been associated with conduction disease, but its prevalence in BS is unknown. Seventy‐six non‐related patients with BS were studied. Clinical characteristics and family risk profile were recorded. Direct sequencing and multiplex ligation‐dependent probe amplification (MLPA) of the SCN5A gene for identification of mutations and larger rearrangements were performed, respectively. Eight patients (10.5%) had point mutations (R27H, E901K, G1743R (detected in three families), V728I, N1443S and E1152X). Patients with mutations had a trend toward a higher proportion of spontaneous type I Brugada electrocardiogram (ECG) (87.5% vs 52.9%, p = 0.06) and had evidence of familial disease (62.5%, vs 23.5%, p = 0.03). The symptoms and risk profile of the carriers were not different from wild‐type probands. There were non‐significant differences in the prevalence of type I ECG, syncope and history of arrhythmia in carriers of selected polymorphisms. None of the patients had any deletion/duplication in the SCN5A gene. In conclusion, 10.5% of our patients had mutations in the SCN5A gene. Patients with mutations seemed to have more spontaneous type I ECG, but no differences in syncope or arrhythmic events compared with patients without mutations. Larger studies are needed to evaluate the role of polymorphisms in the SCN5A in the expression of the phenotype and prognosis. Large rearrangements were not identified in the SCN5A gene using the MLPA technique. 相似文献
50.
Heredero A Perez-Caballero R Otero J Rodríguez-Martínez D Quintana-Villamandos B Rodríguez-Bernal G González-Pinto A Ruiz-Fernandez M Del Cañizo JF 《The International journal of artificial organs》2012,35(4):272-278
Background: Synchronization between the left ventricle and a left ventricular assist device (LVAD) may be important for ventricular unloading and coronary perfusion. We assessed the synchrony between cardiac and LVAD cycles by increasing delays in steps of 100 msec throughout the cycle, under conditions of total and partial left ventricular support. Methods: We studied 7 healthy minipigs weighing 30-40 kg. A 60-cc Berlin Heart Excor LVAD was implanted and connected to a BCM 1200 console, making it possible to synchronize the LVAD systole and the EKG signal with a prefixed delay. We recorded hemodynamic parameters (including aortic, pulmonary, and left ventricular pressure) and LVAD flow for each delay. Results: Intraventricular pressure during LVAD systole was minimized with delays of around 40-80% of one cycle. In addition, total flow was higher under these conditions. Conclusions: This study shows that the synchronous mode of LVAD operation is feasible. Moreover, a delay in device contraction until the second half of the cardiac cycle optimizes ventricular unloading and may eventually improve myocardial recovery. 相似文献